Navigation Links
Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
Date:1/20/2009

PHILADELPHIA, Jan. 20 /PRNewswire/ -- Mealey's Conferences (now HB Litigation Conferences) released its upcoming schedule of CLE accredited teleconferences for tort litigators, plus a professional development opportunity for women in the legal profession.

     Upcoming teleconferences include:

     January 22 - Asbestos Gaskets: Exposure and the State of the Art.

     February 5 - Duragesic/Fentanyl Patch.

February 5 - Nanotechnology: Is it the Next Plastics or the Next Asbestos?

February 23 - Hot Topics in Pharma Litigation: Byetta, Digitek, Yasmin, NuvaRing & More.

February 24 - Defense Perspectives on Attorney General Pharmaceutical Claims.

February 24 - Construction Defect Litigation: Delay, Disruption, Collection Claims in Foreclosure & Contract Disputes.

February 26 - International Asbestos Litigation.

February 12 - Effective Negotiating Skills for Women Lawyers (CLE depends on state bar rules).

Not only can attorneys use these programs to educate practice teams, but can benefit from 2-for-1 pricing (promo code MASSTORTS141 required).

Interested attorneys are encouraged to visit http://www.LitigationConferences.com for more info, plus free articles and audio/video clips from the company's archives covering insurance, reinsurance, toxic torts, construction litigation and complex commercial and financial litigation. Recent audio posts include one of plaintiff attorney Mark Lanier speaking on asbestos last year. New video posts, more than a dozen, are available from last week's banking litigation conference.

    Call us at 484-324-2755 x200.  Email
Kathleen.McFadden@litigationconferences.com or
Lynnsey.PerrinHee@litigationconferences.com.

Teleconferences are accredited for 1.5CLEs and take place from 2pm-3:40pm EST except where noted.

HB Litigation Conferences, fka Mealey's Conferences, is a leading provider of litigation conferences, seminars, and teleconferences with a rich archive of legal education materials and multimedia content. All programs are fully accredited for continuing legal education. For general inquiries write to info@litigationconferences.com.

     CONTACT
     Lynnsey Perrin Hee
     HB Litigation Conferences
     fka Mealey's Conferences
     lynnsey.perrinhee@litigationconferences.com
    (484) 324-2755 x210

'/>"/>
SOURCE HB Litigation Conferences: fka Mealey's Conferences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... ... February 16, 2017 , ... Avomeen & MichBio will be ... will be held at Avomeen Analytical Services (4840 Venture Dr., Ann Arbor, Michigan 48108). ... They provide an opportunity to interact with peers, make new connections and talk bio ...
(Date:2/16/2017)... CALABASAS, Calif. , Feb. 16, 2017 /PRNewswire/ ... on developing groundbreaking therapies to treat severe neurological ... in children treated with AGT-181, the company,s investigational ... syndrome (also known as mucopolysaccharidosis type I, or ... Phase 2 proof-of-concept (POC) study, presented today at ...
(Date:2/16/2017)... 2017 Patient Care services ... telemedicine application, new and leading edge therapies and ... boom worldwide. The healthcare sector as whole continues ... and new therapies for companies such as Reliq ... Biosciences, Inc. (NASDAQ: CLRB ), Cytori ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced today the ... Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at Andrews Memorial ... physician suffering from degenerative disc disease with radiculomyelopathy, as a result of degenerative ...
Breaking Biology Technology:
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, ... on emerging technology, announces the availability of a new report, ... Continue Reading ... ... industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
(Date:1/23/2017)...  The latest mobile market research from Acuity Market ... The quarterly average price of a biometric smartphone decreased ... 2016.  There are now 120 sub-$150 models on the ... just 28 a year ago at an average price ... Most , Acuity Market Intelligence Principal, "Biometric Smartphones are ...
Breaking Biology News(10 mins):